Overview

Ciprofloxacin on Burned Patients

Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
This was a non randomised, multi center, italian study performed in burn patients receiving an antibiotic (ciprofloxacin) in order to treat an active infection. The aim of the study was to validate a pharmacokinetics model useful to verify if a standard dose regimen of ciprofloxacin, given to patients with a compromised metabolism, is a correct dose or instead is over or under dosed.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Ciprofloxacin